tiprankstipranks
Trending News
More News >
Astellas Pharma Inc (JP:4503)
:4503
Japanese Market

Astellas Pharma (4503) Ratios

Compare
3 Followers

Astellas Pharma Ratios

JP:4503's free cash flow for Q3 2024 was ¥0.81. For the 2024 fiscal year, JP:4503's free cash flow was decreased by ¥ and operating cash flow was ¥0.14. See a summary of the company’s cash flow.
Ratios
TTM
Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio
0.93 1.45 1.34 1.47 1.09
Quick Ratio
0.74 1.21 1.12 1.20 0.90
Cash Ratio
0.26 0.52 0.46 0.55 0.40
Solvency Ratio
0.09 0.22 0.23 0.22 0.25
Operating Cash Flow Ratio
0.13 0.45 0.37 0.52 0.28
Short-Term Operating Cash Flow Coverage
0.37 4.37 0.00 0.00 0.65
Net Current Asset Value
¥ -778.88B¥ 101.39B¥ 51.27B¥ -14.93B¥ -161.48B
Leverage Ratios
Debt-to-Assets Ratio
0.28 0.08 0.09 0.12 0.18
Debt-to-Equity Ratio
0.63 0.13 0.15 0.20 0.32
Debt-to-Capital Ratio
0.39 0.12 0.13 0.17 0.24
Long-Term Debt-to-Capital Ratio
0.22 0.03 0.00 0.00 0.00
Financial Leverage Ratio
2.24 1.63 1.60 1.64 1.80
Debt Service Coverage Ratio
0.39 2.47 42.08 83.55 0.77
Interest Coverage Ratio
13.30 15.15 31.46 58.27 81.22
Debt to Market Cap
0.31 0.04 0.00 0.00 0.11
Interest Debt Per Share
566.05 114.72 117.69 151.09 221.90
Net Debt to EBITDA
3.43 -0.74 -0.43 -0.22 0.30
Profitability Margins
Gross Profit Margin
81.76%81.01%80.48%80.31%78.73%
EBIT Margin
2.31%9.29%12.49%11.82%19.09%
EBITDA Margin
12.18%15.83%18.60%17.59%24.32%
Operating Profit Margin
7.77%8.76%12.01%10.89%18.76%
Pretax Profit Margin
1.56%8.72%12.10%11.63%18.86%
Net Profit Margin
1.06%6.50%9.57%9.65%15.02%
Continuous Operations Profit Margin
1.06%6.42%9.54%9.65%15.15%
Net Income Per EBT
68.26%74.58%79.09%82.98%79.65%
EBT Per EBIT
20.04%99.50%100.77%106.82%100.56%
Return on Assets (ROA)
0.48%4.02%5.32%5.30%8.43%
Return on Equity (ROE)
1.07%6.55%8.50%8.70%15.16%
Return on Capital Employed (ROCE)
5.46%7.69%9.46%8.09%16.06%
Return on Invested Capital (ROIC)
3.09%5.50%7.49%6.71%10.43%
Return on Tangible Assets
1.00%6.31%8.83%9.01%14.89%
Earnings Yield
0.58%2.88%3.51%3.82%6.23%
Efficiency Ratios
Receivables Turnover
2.93 3.55 3.39 3.64 3.75
Payables Turnover
1.58 2.06 1.94 1.97 1.61
Inventory Turnover
1.18 1.65 1.65 1.50 1.83
Fixed Asset Turnover
5.46 5.30 4.82 4.72 4.84
Asset Turnover
0.45 0.62 0.56 0.55 0.56
Working Capital Turnover Ratio
13.77 5.42 5.02 7.16 6.07
Cash Conversion Cycle
204.03 146.09 139.92 158.55 69.76
Days of Sales Outstanding
124.73 102.86 107.70 100.25 97.38
Days of Inventory Outstanding
310.41 220.74 220.83 243.39 199.18
Days of Payables Outstanding
231.11 177.51 188.61 185.09 226.80
Operating Cycle
435.14 323.60 328.53 343.64 296.56
Cash Flow Ratios
Operating Cash Flow Per Share
96.18 180.09 139.18 165.22 118.32
Free Cash Flow Per Share
50.18 131.44 97.85 123.53 76.81
CapEx Per Share
46.00 48.65 41.33 41.70 41.51
Free Cash Flow to Operating Cash Flow
0.52 0.73 0.70 0.75 0.65
Dividend Paid and CapEx Coverage Ratio
0.87 1.74 1.59 2.00 1.47
Capital Expenditure Coverage Ratio
2.09 3.70 3.37 3.96 2.85
Operating Cash Flow Coverage Ratio
0.17 1.64 1.21 1.10 0.54
Operating Cash Flow to Sales Ratio
0.11 0.22 0.20 0.25 0.17
Free Cash Flow Yield
3.06%6.98%5.12%7.26%4.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
172.65 34.72 28.49 26.21 16.04
Price-to-Sales (P/S) Ratio
1.84 2.26 2.73 2.53 2.41
Price-to-Book (P/B) Ratio
1.84 2.27 2.42 2.28 2.43
Price-to-Free Cash Flow (P/FCF) Ratio
32.71 14.33 19.53 13.78 21.76
Price-to-Operating Cash Flow Ratio
17.06 10.46 13.73 10.30 14.12
Price-to-Earnings Growth (PEG) Ratio
-2.09 -1.81 8.60 -0.70 -1.69
Price-to-Fair Value
1.84 2.27 2.42 2.28 2.43
Enterprise Value Multiple
18.49 13.52 14.24 14.16 10.21
EV to EBITDA
18.49 13.52 14.24 14.16 10.21
EV to Sales
2.25 2.14 2.65 2.49 2.48
EV to Free Cash Flow
40.15 13.59 18.96 13.57 22.41
EV to Operating Cash Flow
20.95 9.92 13.33 10.15 14.55
Tangible Book Value Per Share
-154.20 339.03 288.61 242.67 150.92
Shareholders’ Equity Per Share
889.98 828.54 789.48 746.38 687.12
Tax and Other Ratios
Effective Tax Rate
0.32 0.25 0.21 0.17 0.20
Revenue Per Share
894.27 834.40 700.74 672.83 693.34
Net Income Per Share
9.50 54.24 67.08 64.93 104.15
Tax Burden
0.68 0.75 0.79 0.83 0.80
Interest Burden
0.68 0.94 0.97 0.98 0.99
Research & Development to Revenue
0.18 0.18 0.19 0.18 0.17
SG&A to Revenue
0.46 0.42 0.42 0.40 0.38
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
10.12 2.48 1.64 2.11 0.90
Currency in JPY
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis